OR WAIT null SECS
October 02, 2007
Orally disintegrating tablets (ODTs) continue to attract attention as an alternative to conventional oral dosage forms.
September 13, 2007
Company and People Notes: Baxter and Halozyme Expand Relationship, Crucell Names COO, More.
June 22, 2007
Double-digit growth is projected for the US generic drug market, and the industry positions for opportunities in biosimilars.
March 01, 2007
Brussels (Feb. 13)-The European Generic Medicines Association raised concerns over what it terms ?the serious lack? of resources available to member states in the European Union (EU) to deal with the regulatory workload and bottleneck in new registrations caused by the new Decentralized Procedure (DCP) for approving drugs in Europe.
October 05, 2006
Rockville, MD (Sept. 28)-The US Food and Drug Administration has released the draft guidance for industry ?Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases.?
September 02, 2006
I recently embarked on a quest: to investigate industry's use of the words, "generic" and "biosimilar" when describing a biologic molecule. An English major at heart, I was wrapped up in a news story that was partly about science, partly about words.
October 01, 2005
Chemical purity is the most important quality characteristic of a pharmaceutical substance. This article describes the latest scientific and technological advances to meet recent pharmacopoeial and regulatory requirements regarding the control of organic impurities in synthetically produced active substances. Future developments and suggestions for those working in quality control and raw material selection are discussed.